Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway.
Maria SavinoClaudio Carmine GuidaMaria NardellaEmanuele MurgoBartolomeo AugelloGiuseppe MerlaSalvatore De CosmoAntonio Fernando SavinoRoberto TarquiniFrancesco CeiFilippo AucellaGianluigi MazzoccoliPublished in: Biomedicines (2022)
Heme is a member of the porphyrins family of cyclic tetrapyrroles and influences various cell processes and signalling pathways. Enzyme deficiencies in the heme biosynthetic pathway provoke rare human inherited metabolic diseases called porphyrias. Protein levels and activity of enzymes involved in the heme biosynthetic pathway and especially 5'-Aminolevulinate Synthase 1 are featured by 24-h rhythmic oscillations driven by the biological clock. Heme biosynthesis and circadian pathways intermingle with mutual modulatory roles. Notably, heme is a ligand of important cogs of the molecular clockwork, which upon heme binding recruit co-repressors and inhibit the transcription of numerous genes enriching metabolic pathways and encoding functional proteins bringing on crucial cell processes. Herein, we assessed mRNA levels of circadian genes in patients suffering from porphyrias and found several modifications of core clock genes and clock-controlled genes expression, associated with metabolic and electrolytic changes. Overall, our results show an altered expression of circadian genes accompanying heme biosynthesis disorders and confirm the need to deepen the knowledge of the mechanisms through which the alteration of the circadian clock circuitry could take part in determining signs and symptoms of porphyria patients and then again could represent a target for innovative therapeutic strategies.
Keyphrases
- genome wide
- end stage renal disease
- poor prognosis
- bioinformatics analysis
- genome wide identification
- newly diagnosed
- ejection fraction
- binding protein
- chronic kidney disease
- prognostic factors
- single cell
- peritoneal dialysis
- healthcare
- endothelial cells
- stem cells
- cell therapy
- transcription factor
- patient reported outcomes
- gene expression